tirzepatide heart disease UC Irvine researchers project cardiac benefits from weight-loss medication 🚨 Breaking News: Real-World Data

G.MalesterB.RindlerM

[DOI] [PMC free article] [PubMed] 49.Meier, J

Weight Management in Hashimoto's Thyroiditis Weight gain is a common and distressing symptom for many individuals with Hashimoto's thyroiditis, often persisting even after thyroid hormone replacement has normalised TSH levels

When to Consult a Provider You should reach out to a healthcare professional if you experience severe pain at the injection site, signs of an allergic reaction (like hives or swelling), or if you have questions about how the medication is interacting with other health conditions

Treatment with semaglutide in post-bariatric patients is of clear benefit

Clinical trials show semaglutide produces an average body weight reduction of 15% or more, and tirzepatide produces reductions exceeding 20% in some populations